Table 2.
Efficacy assessment of two groups
| Efficacy assessment | DEB-TACE group | PVA-TACE group | P |
|---|---|---|---|
|
| |||
| Shunt recurrence (yes/no, %) | 3/23, 11.5/88.5 | 2/30, 6.3/93.7 | 0.648 |
| Objective response (CR + PR/SD + PD, %) | 8/18, 30.8/69.2 | 4/28, 12.5/87.5 | 0.088 |
| Disease control (CR + PR+SD/PD, %) | 18/8, 69.2/30.8 | 12/20, 37.5/62.5 | 0.016 |
Abbreviations: CR, complete response; DEB-TACE, transarterial chemoembolization with drug-eluting beads; PD, progression disease; PR, partial response; PVA-TACE, polyvinyl alcohol plus transarterial chemoembolization; SD, stable disease.